Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 81001 - 81025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tretinoin	Approved Investigational Nutraceutical	CSGALNACT1	55790	upregulated	Tretinoin results in increased expression of CSGALNACT1 mRNA	8p21.3	A24454
Tretinoin	Approved Investigational Nutraceutical	CSGALNACT2	55454	upregulated	Tretinoin results in increased expression of CSGALNACT2 mRNA	10q11.21	A24453
Tretinoin	Approved Investigational Nutraceutical	CSNK2B	1460	downregulated	Tretinoin results in decreased expression of CSNK2B mRNA	6p21.33	A24466
Tretinoin	Approved Investigational Nutraceutical	CSPG5	10675	downregulated	Tretinoin results in decreased expression of CSPG5 mRNA	3p21.31	A24454
Tretinoin	Approved Investigational Nutraceutical	CSRNP2	81566	upregulated	Tretinoin results in increased expression of CSRNP2 mRNA	12q13.12	A24453
Tretinoin	Approved Investigational Nutraceutical	CSRNP3	80034	upregulated	Tretinoin results in increased expression of CSRNP3 mRNA	2q24.3	A24453
Tretinoin	Approved Investigational Nutraceutical	CSRP1	1465	upregulated	Tretinoin results in increased expression of CSRP1 mRNA	1q32.1	A24376 A24454
Tretinoin	Approved Investigational Nutraceutical	CSRP2	1466	downregulated	Tretinoin results in decreased expression of CSRP2 mRNA	12q21.2	A24454
Tretinoin	Approved Investigational Nutraceutical	CSRP3	8048	upregulated	Tretinoin results in increased expression of CSRP3 mRNA	11p15.1	A24469
Tretinoin	Approved Investigational Nutraceutical	CST1	1469	upregulated	Tretinoin results in increased expression of CST1 mRNA	20p11.21	A24454
Tretinoin	Approved Investigational Nutraceutical	CST3	1471	upregulated	Tretinoin results in increased expression of CST3 mRNA	20p11.21	A24376 A24454
Tretinoin	Approved Investigational Nutraceutical	CST6	1474	upregulated	Tretinoin results in increased expression of CST6 mRNA	11q13.1	A24455 A24456
Tretinoin	Approved Investigational Nutraceutical	CSTA	1475	upregulated	Tretinoin results in increased expression of CSTA mRNA	3q21.1	A24466 A24456
Tretinoin	Approved Investigational Nutraceutical	CSTF2T	23283	downregulated	Tretinoin results in decreased expression of CSTF2T mRNA	10q21.1	A24454
Tretinoin	Approved Investigational Nutraceutical	CTGF	1490	upregulated	Tretinoin results in increased expression of CTGF mRNA	6q23.2	A24456
Tretinoin	Approved Investigational Nutraceutical	CTHRC1	115908	upregulated	Tretinoin results in increased expression of CTHRC1 mRNA	8q22.3	A24454
Tretinoin	Approved Investigational Nutraceutical	CTIF	9811	downregulated	Tretinoin results in decreased expression of CTIF mRNA	18q21.1	A24376
Tretinoin	Approved Investigational Nutraceutical	CTNNA1	1495	downregulated	Tretinoin results in decreased expression of CTNNA1 mRNA	5q31.2	A22303
Tretinoin	Approved Investigational Nutraceutical	CTNNAL1	8727	downregulated	Tretinoin results in decreased expression of CTNNAL1 mRNA	9q31.3	A24376
Tretinoin	Approved Investigational Nutraceutical	CTNNB1	1499	downregulated	Tretinoin results in decreased expression of CTNNB1 mRNA	3p22.1	A24488
Tretinoin	Approved Investigational Nutraceutical	CTNNBIP1	56998	downregulated	Tretinoin results in decreased expression of CTNNBIP1 mRNA	1p36.22	A24454
Tretinoin	Approved Investigational Nutraceutical	CTPS1	1503	downregulated	Tretinoin results in decreased expression of CTPS1 mRNA	1p34.2	A24464
Tretinoin	Approved Investigational Nutraceutical	CTSA	5476	upregulated	Tretinoin results in increased expression of CTSA mRNA	20q13.12	A24453
Tretinoin	Approved Investigational Nutraceutical	CTSB	1508	upregulated	Tretinoin results in increased expression of CTSB mRNA	8p23.1	A24454 A24453
Tretinoin	Approved Investigational Nutraceutical	CTSC	1075	downregulated	Tretinoin results in decreased expression of CTSC mRNA	11q14.2	A24453

Displaying entries 81001 - 81025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability